EP3716992
NOTKUN VEGF-BLOKKA Í MEÐFERÐ VIÐ ÆÐAMYNDUNARRÖSKUN Í AUGUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.11.2018EP published:
10.8.2022EP application number:
18825837.0
EP translation filed:
1.9.2022Grant published:
15.11.2022EPO information:
European Patent Register
Max expiry date:
28.11.2038Expiry date:
28.11.2026Next due date:
30.11.2026
Title in English:
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERSLanguage of the patent:
English
Timeline
Today
29.11.2018EP application
10.8.2022EP Publication
1.9.2022Translation submitted
15.11.2022Registration published
28.11.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
VITTI, Robert L.Address:
Tarrytown New York 10591, US
Name:
BERLINER, Alyson J.Address:
Tarrytown New York 10591, US
Name:
CHU, KarenAddress:
Tarrytown New York 10591, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201762593033 PDate:
30.11.2017Country:
US
Number:
201862644425 PDate:
17.3.2018Country:
US
Number:
201862748782 PDate:
22.10.2018Country:
US
Classification
Categories:
A61K 38/17, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 20.10.2022
Expires: 28.11.2023
Payer: Patice ehf.
Number: 5
Paid: 20.10.2022
Expires: 28.11.2023
Payer: Patice ehf.
Number: 5
Paid: 20.10.2022
Expires: 28.11.2023
Payer: Patice ehf.
Number: 6
Paid: 6.11.2023
Expires: 28.11.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 25.10.2024
Expires: 28.11.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 17.11.2025
Expires: 28.11.2026
Payer: Árnason Faktor ehf.